These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21091879)

  • 1. Circulating sex hormones play no role in the association between sexual activity and the risk of prostate cancer.
    Ahmadi H; Allameh F; Baradaran N; Montaser-Kouhsari L; Bazargan-Hejazi S; Salem S; Mehrsai A; Pourmand G
    J Sex Med; 2011 Mar; 8(3):905-13. PubMed ID: 21091879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones.
    Baradaran N; Ahmadi H; Salem S; Lotfi M; Jahani Y; Baradaran N; Mehrsai AR; Pourmand G
    Prostate; 2009 Dec; 69(16):1744-50. PubMed ID: 19676082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men.
    Honda GD; Bernstein L; Ross RK; Greenland S; Gerkins V; Henderson BE
    Br J Cancer; 1988 Mar; 57(3):326-31. PubMed ID: 3355774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating steroid hormones and the risk of prostate cancer.
    Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy.
    Salonia A; Abdollah F; Capitanio U; Suardi N; Briganti A; Gallina A; Colombo R; Ferrari M; Castagna G; Rigatti P; Montorsi F
    Clin Cancer Res; 2012 Jul; 18(13):3648-57. PubMed ID: 22589393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical characteristics and factors related to sexual development and behaviour and the risk for prostatic cancer.
    Hayes RB; de Jong FH; Raatgever J; Bogdanovicz J; Schroeder FH; van der Maas P; Oishi K; Yoshida O
    Eur J Cancer Prev; 1992 Apr; 1(3):239-45. PubMed ID: 1467769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials.
    Cunningham GR; Stephens-Shields AJ; Rosen RC; Wang C; Ellenberg SS; Matsumoto AM; Bhasin S; Molitch ME; Farrar JT; Cella D; Barrett-Connor E; Cauley JA; Cifelli D; Crandall JP; Ensrud KE; Fluharty L; Gill TM; Lewis CE; Pahor M; Resnick SM; Storer TW; Swerdloff RS; Anton S; Basaria S; Diem S; Tabatabaie V; Hou X; Snyder PJ
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1146-55. PubMed ID: 25548978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypogonadism in male patients with cancer.
    Garcia JM; Li H; Mann D; Epner D; Hayes TG; Marcelli M; Cunningham GR
    Cancer; 2006 Jun; 106(12):2583-91. PubMed ID: 16688773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal predictors of prostate cancer: a meta-analysis.
    Shaneyfelt T; Husein R; Bubley G; Mantzoros CS
    J Clin Oncol; 2000 Feb; 18(4):847-53. PubMed ID: 10673527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigative clinical study on prostate cancer part IX and X: estradiol and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population after radical prostatectomy.
    Porcaro AB; Ghimenton C; Petrozziello A; Sava T; Migliorini F; Romano M; Caruso B; Cocco C; Antoniolli SZ; Lacola V; Rubilotta E; Monaco C
    Anticancer Res; 2012 Oct; 32(10):4523-32. PubMed ID: 23060581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
    Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
    Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males.
    Moreno-Pérez O; Escoín C; Serna-Candel C; Portilla J; Boix V; Alfayate R; González-Sánchez V; Mauri M; Sánchez-Payá J; Picó A
    J Sex Med; 2010 Aug; 7(8):2873-83. PubMed ID: 20626606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of relationship between steroid hormone levels and prostate cancer tumor grade.
    Sher DJ; Mantzoros C; Jacobus S; Regan MM; Lee GS; Oh WK
    Urology; 2009 Feb; 73(2):356-61; discussion 361-2. PubMed ID: 19036418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
    Rannikko S; Adlercreutz H
    Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.